Latest News : 2014 : September

Keith A. Webster, Ph.D.

Miller School-Based Vascular Biotechnology Company Receives Start-Up Funding

In the first joint investment resulting from a novel public/private alliance, Integene International Holdings, a vascular biotechnology company led by Keith A. Webster, Ph.D., professor of molecular and cellular pharmacology and the Walter G. Ross Distinguished Chair in Vascular Biology, has received $600,000 in start-up capital.

Read more »